Diebold Nixdorf (DBD) Misses Q1 EPS by $1.41
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $73.06 +1.14%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of ($1.61), $1.41 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $829.8 million versus the consensus estimate of $936.6 million.
GUIDANCE:
Diebold Nixdorf sees FY2022 revenue of $3.7-3.9 billion, versus the consensus of $4.04 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
